<SEC-DOCUMENT>0001157523-19-001479.txt : 20190702
<SEC-HEADER>0001157523-19-001479.hdr.sgml : 20190702
<ACCEPTANCE-DATETIME>20190702161558
ACCESSION NUMBER:		0001157523-19-001479
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20190702
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190702
DATE AS OF CHANGE:		20190702

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			USANA HEALTH SCIENCES INC
		CENTRAL INDEX KEY:			0000896264
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				870500306
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35024
		FILM NUMBER:		19937529

	BUSINESS ADDRESS:	
		STREET 1:		3838 WEST PARKWAY BLVD.
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84120-6336
		BUSINESS PHONE:		8019547100

	MAIL ADDRESS:	
		STREET 1:		3838 WEST PARKWAY BLVD.
		STREET 2:		3838 WEST PARKWAY BLVD.
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84120-6336

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	USANA INC
		DATE OF NAME CHANGE:	19930125
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a52008353.htm
<DESCRIPTION>USANA HEALTH SCIENCES. INC. 8-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Business Wire
         Document created using EDGARfilings PROfile 6.0.0.0
         Copyright 1995 - 2019 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div><br>
  </div>
  <div>
    <div><br>
    </div>
    <div>&#160;</div>
    <div style="text-align: center; font-size: 12pt; font-weight: bold;">UNITED STATES</div>
    <div>&#160;</div>
    <div style="text-align: center; font-size: 12pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION<br>
      <br>
      WASHINGTON, D.C. 20549</div>
    <div>&#160;</div>
    <div style="text-align: center; font-size: 12pt;">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</div>
    <div>&#160;</div>
    <div style="text-align: center; font-size: 12pt; font-weight: bold;">FORM 8-K</div>
    <div>&#160;</div>
    <div style="text-align: center; font-size: 12pt;">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</div>
    <div>&#160;</div>
    <div style="text-align: center; font-size: 12pt; font-weight: bold;">CURRENT REPORT</div>
    <div>&#160;</div>
    <div style="text-align: center;">Pursuant to Section 13 or 15(d) of</div>
    <div>&#160;</div>
    <div style="text-align: center;">the Securities Exchange Act of 1934</div>
    <div>&#160;</div>
    <div style="text-align: center;">Date of Report (Date of Earliest Event Reported):<br>
      July 2, 2019</div>
    <div>&#160;</div>
    <div style="text-align: center; font-size: 24pt; font-weight: bold;">USANA HEALTH SCIENCES, INC.</div>
    <div style="text-align: center;">(Exact name of registrant as specified in its charter)</div>
    <div>&#160;</div>
    <div style="text-align: center;">Utah</div>
    <div style="text-align: center;">(State or other jurisdiction of incorporation)</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zadb50188e83749dab44673d5f90c46b2">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center;">001-35024</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center;">87-0500306</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center;">(Commission File No.)</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center;">(IRS Employer Identification</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center;">3838 West Parkway Boulevard<br>
      Salt Lake City, Utah 84120<br>
      (Address of principal executive offices, Zip Code)</div>
    <div style="text-align: center;">Registrant's telephone number, including area code: (801) 954-7100</div>
    <div>&#160;</div>
    Check the appropriate box below if the Form 8-K &#64257;ling is intended to simultaneously satisfy the &#64257;ling obligation of the registrant under any of the following provisions:
    <div>&#160;</div>
    <div>[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
    <div style="margin-right: 13.5pt; margin-left: 6pt;"> <br>
    </div>
    <div>[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
    <div>&#160;</div>
    <div>[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
    <div>&#160;</div>
    <div>[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
    <div>&#160;</div>
    <div>Securities registered pursuant to Section 12(b) of the Act:</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb8814053dcd847448f436e08ebcd785e">

        <tr>
          <td style="width: 50%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-indent: -145.2pt; margin-right: 8.45pt; margin-left: 180.1pt;">Title of each class&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Trading</div>
            <div style="text-indent: -145.2pt; margin-right: 8.45pt; margin-left: 180.1pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Symbol(s)</div>
          </td>
          <td style="width: 50%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center;">Name of each exchange on which registered</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div>Common Stock, $0.001 par value per share&#160; &#160; &#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; &#160; USNA</div>
            <div>&#160;</div>
          </td>
          <td style="width: 50%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center;">New York Stock Exchange</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div>Indicate by check mark whether the registrant is an emerging growth company as de&#64257;ned in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>
    <div><br>
    </div>
    <div style="margin-left: 355.5pt; text-align: right;">Emerging growth company&#160;&#160; &#9744;</div>
    <div>&#160;</div>
    <div>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised &#64257;nancial accounting standards provided pursuant to Section 13(a) of the Exchange
      Act.&#160;&#160; &#9744;</div>
    <div style="font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div></div>
    <div><br>
    </div>
    <div><font style="font-weight: bold;">Item&#160;2.02</font><font style="text-indent: 0px; font-size: 5.14pt;" id="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-weight: bold;">Results of Operations and Financial Condition.</font></div>
    <div><br>
    </div>
    <div>On July 2, 2019, USANA Health Sciences, Inc. (the &#8220;Company&#8221; or &#8220;USANA&#8221;) issued a press release announcing its preliminary financial results for the second quarter ended June 29, 2019 along with updated outlook for the full year 2019.&#160; A copy of
      the press release is furnished herewith as Exhibit to this Current Report on Form 8-K and is incorporated herein by reference.&#160; This document will be posted on the Company&#8217;s corporate website, www.usana.com.</div>
    <div><br>
    </div>
    <div>The information in this Current Report is being furnished and shall not be deemed &#8220;filed&#8221; for the purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information
      in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended. The furnishing of the information in this Current Report is not intended to, and does
      not, constitute a representation that such furnishing is required by Regulation FD or that the information this Current Report contains is material investor information that is not otherwise publicly available.</div>
    <div><br>
    </div>
    <div><font style="font-weight: bold;">Item 7.01</font><font style="text-indent: 0px; font-size: 5.14pt;" id="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-weight: bold;">Regulation FD Disclosure</font></div>
    <div><br>
    </div>
    <div>The information disclosed above under Item 2.02, as well as the exhibit attached under Item 9.01 below is incorporated herein by reference.</div>
    <div><br>
    </div>
    <div><font style="font-weight: bold;">Item&#160;9.01</font><font style="text-indent: 0px; font-size: 5.14pt;" id="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-weight: bold;">Financial Statements and Exhibits.</font></div>
    <div><br>
    </div>
    <div style="margin-left: 72pt;">(d) Exhibits</div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="border-bottom: 0px none; border-right: 0px none; vertical-align: bottom; width: 4%; padding: 0px 0px 2px;" colspan="1">&#160;</td>
            <td style="border-bottom: 2px solid rgb(0, 0, 0); border-right: 0px none; vertical-align: bottom; width: 8%; padding-top: 0px; padding-right: 0px; padding-left: 0px; font-weight: bold;">Exhibit No.</td>
            <td style="border-bottom: 0px none; border-right: 0px none; vertical-align: bottom; width: 3%; padding: 0px 0px 2px;" colspan="1">&#160;</td>
            <td style="border-bottom: 0px none; border-right: 0px none; vertical-align: bottom; width: 85.28%; padding-bottom: 2px;">
              <div style="font-weight: bold;">Description</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4%; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="width: 8%; vertical-align: bottom;">99.1<br>
            </td>
            <td style="width: 3%; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="width: 85.28%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
              <div>Press release issued by USANA Health Sciences, Inc. dated July 2, 2019 (furnished herewith).</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div> <br>
    </div>
    <div style="text-align: center; font-weight: bold;">SIGNATURES</div>
    <div>&#160;</div>
    <div>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>
    <div>&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" id="zc4a63dbdb4634eed82ffd29f0c15a867" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 55%;">
              <div>&#160;</div>
            </td>
            <td style="width: 45%; font-weight: bold;">USANA HEALTH SCIENCES, INC.</td>
          </tr>
          <tr>
            <td style="width: 55%;">
              <div>&#160;</div>
            </td>
            <td style="width: 45%;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%;">
              <div>&#160;</div>
            </td>
            <td style="width: 45%;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%;">
              <div>&#160;</div>
            </td>
            <td style="width: 45%;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%;">
              <div>&#160;</div>
            </td>
            <td style="width: 45%;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%;">
              <div>&#160;</div>
            </td>
            <td style="width: 45%;">
              <div><font style="font-weight: bold;">By:</font> <u>/s/ G. Douglas Hekking &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; </u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%;">
              <div>&#160;</div>
            </td>
            <td style="width: 45%;">G. Douglas Hekking, Chief Financial Officer</td>
          </tr>

      </table>
    </div>
    <div style="font-weight: 400; font-family: 'Times New Roman',Times,serif;"><br>
    </div>
    <div>Date:&#160; July 2, 2019</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div> <br>
    </div>
    <div style="text-align: center; font-weight: bold;">Exhibit Index</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z8e0c3244a5184990a8d5e7c5604c3389">

        <tr>
          <td style="border-bottom: 0px none; border-right: 0px none; vertical-align: bottom; width: 4%; padding: 0px 0px 2px;" colspan="1">&#160;</td>
          <td style="border-bottom: 2px solid rgb(0, 0, 0); border-right: 0px none; vertical-align: bottom; width: 8%; padding-top: 0px; padding-right: 0px; padding-left: 0px; font-weight: bold;">Exhibit No.</td>
          <td style="border-bottom: 0px none; border-right: 0px none; vertical-align: bottom; width: 3%; padding: 0px 0px 2px;" colspan="1">&#160;</td>
          <td style="border-bottom: 0px none; border-right: 0px none; vertical-align: bottom; width: 85.28%; padding-bottom: 2px;">
            <div style="font-weight: bold;">Description</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: bottom;" colspan="1">&#160;</td>
          <td style="width: 8%; vertical-align: bottom;"><a href="a52008353ex99_1.htm">99.1</a><br>
          </td>
          <td style="width: 3%; vertical-align: bottom;" colspan="1">&#160;</td>
          <td style="width: 85.28%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
            <div><a href="a52008353ex99_1.htm">Press release issued by USANA Health Sciences, Inc. dated July 2, 2019 (furnished herewith).</a></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a52008353ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Business Wire
         Document created using EDGARfilings PROfile 6.0.0.0
         Copyright 1995 - 2019 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
  </div>
  <div> <br>
  </div>
  <div>
    <div class="bw-release">
      <div class="bw-release">
        <h1 style="text-align: center; list-style-position:inside;FONT-SIZE: 14pt;"> <b>USANA Health Sciences Provides Preliminary Second Quarter Results and Updates Fiscal Year 2019 Outlook </b> </h1>
        <div class="bw-release-body">
          <div class="bw-release-table-js bw-release-story">
            <p>SALT LAKE CITY--(BUSINESS WIRE)--July 2, 2019--USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary second quarter results and updated its outlook for fiscal year 2019. The Company anticipates that second quarter 2019 net
              sales will range between $253 and $256 million, compared with $301 million in the prior-year period, and earnings per diluted share will range between $0.91 and $0.95 per diluted share, compared with $1.36 per diluted share in the prior-year
              period. </p>
            <p> Upon reporting its first quarter results on April 30, 2019, the Company disclosed the challenging consumer environment it encountered in China during the quarter, due largely to the negative media coverage of the health products and direct
              selling industries in China. The Company also disclosed that it expected to see a more typical operating environment in China beginning in the second quarter, and that its business would continue to accelerate during the second half of the
              year. During the second quarter, however, the Company continued to encounter a challenging consumer environment in China and, consequently, net sales for the quarter were softer than previously expected. The Company now believes that it may
              experience sales softness in China throughout 2019, and is revising its full-year guidance as follows: </p>
            <div> </div>
            <table cellspacing="0" style="margin-bottom: 10.0px; font-size: 10pt;" id="zdeffed23dacf42d78323e76bf1296f60">

                <tr>
                  <td style="vertical-align: top;border-top: solid black 1.0pt;border-bottom: solid black 1.0pt;border-left: solid black 1.0pt;border-right: solid black 1.0pt;" rowspan="1" colspan="1">
                    <p style="margin-bottom: 0px; margin-top: 0px;"> &#160; </p>
                  </td>
                  <td style="vertical-align: top;border-top: solid black 1.0pt;border-bottom: solid black 1.0pt;border-right: solid black 1.0pt;" rowspan="1" colspan="1">
                    <p style="text-align: center; list-style-position:inside;margin-bottom: 0px; margin-top: 0px;"> <b>Q2 2019 <br>
                        Preliminary <br>
                        Results</b> </p>
                  </td>
                  <td style="vertical-align: top;border-top: solid black 1.0pt;border-bottom: solid black 1.0pt;border-right: solid black 1.0pt;" rowspan="1" colspan="1">
                    <p style="text-align: center; list-style-position:inside;margin-bottom: 0px; margin-top: 0px;"> <b>Previous </b> </p>
                    <p style="text-align: center; list-style-position:inside;margin-bottom: 0px; margin-top: 0px;"> <b>Full-Year 2019</b> </p>
                    <p style="text-align: center; list-style-position:inside;margin-bottom: 0px; margin-top: 0px;"> <b>Guidance Range</b> </p>
                  </td>
                  <td style="vertical-align: top;border-top: solid black 1.0pt;border-bottom: solid black 1.0pt;border-right: solid black 1.0pt;" rowspan="1" colspan="1">
                    <p style="text-align: center; list-style-position:inside;margin-bottom: 0px; margin-top: 0px;"> <b>Revised </b> </p>
                    <p style="text-align: center; list-style-position:inside;margin-bottom: 0px; margin-top: 0px;"> <b>Full-Year 2019</b> </p>
                    <p style="text-align: center; list-style-position:inside;margin-bottom: 0px; margin-top: 0px;"> <b>Guidance Range</b> </p>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align: top;border-bottom: solid black 1.0pt;border-left: solid black 1.0pt;border-right: solid black 1.0pt;" rowspan="1" colspan="1">
                    <p style="text-align: center; list-style-position:inside;margin-bottom: 0px; margin-top: 0px;"> Net sales </p>
                  </td>
                  <td style="vertical-align: top;border-bottom: solid black 1.0pt;border-right: solid black 1.0pt;" rowspan="1" colspan="1">
                    <p style="text-align: center; list-style-position:inside;margin-bottom: 0px; margin-top: 0px;"> $253 - $256 million </p>
                  </td>
                  <td style="vertical-align: top;border-bottom: solid black 1.0pt;border-right: solid black 1.0pt;" rowspan="1" colspan="1">
                    <p style="text-align: center; list-style-position:inside;margin-bottom: 0px; margin-top: 0px;"> $1.21 - $1.26 billion </p>
                  </td>
                  <td style="vertical-align: top;border-bottom: solid black 1.0pt;border-right: solid black 1.0pt;" rowspan="1" colspan="1">
                    <p style="text-align: center; list-style-position:inside;margin-bottom: 0px; margin-top: 0px;"> $1.02 - $1.06 billion </p>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align: top;border-bottom: solid black 1.0pt;border-left: solid black 1.0pt;border-right: solid black 1.0pt;" rowspan="1" colspan="1">
                    <p style="text-align: center; list-style-position:inside;margin-bottom: 0px; margin-top: 0px;"> EPS - diluted </p>
                  </td>
                  <td style="vertical-align: top;border-bottom: solid black 1.0pt;border-right: solid black 1.0pt;" rowspan="1" colspan="1">
                    <p style="text-align: center; list-style-position:inside;margin-bottom: 0px; margin-top: 0px;"> $0.91 - $0.95 </p>
                  </td>
                  <td style="vertical-align: top;border-bottom: solid black 1.0pt;border-right: solid black 1.0pt;" rowspan="1" colspan="1">
                    <p style="text-align: center; list-style-position:inside;margin-bottom: 0px; margin-top: 0px;"> $5.00 - $5.35 </p>
                  </td>
                  <td style="vertical-align: top;border-bottom: solid black 1.0pt;border-right: solid black 1.0pt;" rowspan="1" colspan="1">
                    <p style="text-align: center; list-style-position:inside;margin-bottom: 0px; margin-top: 0px;"> $3.70 - $4.10 </p>
                  </td>
                </tr>

            </table>
            <p> &#8220;We continued to see a very challenging market in China throughout the second quarter, and these market conditions had a more significant impact on our results than we anticipated in late April,&#8221; said Kevin Guest, Chief Executive Officer.
              &#8220;We began executing our planned promotional activity for 2019 during the second quarter, including in China. The promotions we offered have historically generated meaningful sales and customer growth, but did not generate the results we
              anticipated during the second quarter, as consumer sentiment remained low. Although we are confident that our strategy will drive long-term growth in the business, we now believe that it may take several months for consumer sentiment to
              return to normal in China.&#8221; </p>
            <p> Final second quarter results will be released after the close of market on Tuesday, July 23, 2019. The above statements reflect the Company&#8217;s preliminary estimates and views on market trends observed in the second quarter of 2019 and are
              based on information available as of the date hereof. </p>
            <p> <b>About USANA</b> </p>
            <p> USANA develops and manufactures high-quality nutritional supplements, healthy foods and personal care products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong
              Kong, China, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the United Kingdom, Thailand, France, Belgium, Colombia, Indonesia, Germany, Spain, Romania, and Italy. More information on USANA can be
              found at <b>www.usana.com</b>. </p>
            <div> </div>
            <p> <b>Safe Harbor</b> </p>
            <p> This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these
              forward-looking statements, which involve a number of risks and uncertainties, including: regulatory, economic, and consumer confidence risks in China; global economic conditions generally; reliance upon our network of independent Associates;
              risk associated with governmental regulation of our business model, products, manufacturing, and marketing activities; adverse publicity risks globally; risks associated with our international expansion and operations; and risks associated
              with the internal investigation into BabyCare&#8217;s operations. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the
              Securities and Exchange Commission. The forward-looking statements set forth our beliefs as of the date hereof. We do not undertake any obligation to update any forward-looking statement after the date hereof, except as required by law. </p>
          </div>
          <div class="bw-release-contact">
            <h2 style="FONT-SIZE: 14pt;">Contacts</h2>
            <p> Investors contact: <br>
              Patrique Richards <br>
              Investor Relations <br>
              (801) 954-7961 <br>
              investor.relations@us.usana.com </p>
            <p> Media contact: <br>
              Dan Macuga <br>
              Public Relations <br>
              (801) 954-7280 </p>
          </div>
        </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
